(Q45978282)

18 December 2017

title

Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. (English)

1 reference

18 December 2017

1 reference

Shaun McKenzie

1

1 reference

18 December 2017

Rebecca Nelson

2

1 reference

18 December 2017

Brian Mailey

3

1 reference

18 December 2017

Wendy Lee

4

1 reference

18 December 2017

Vincent Chung

5

1 reference

18 December 2017

Stephen Shibata

6

1 reference

18 December 2017

Julio Garcia-Aguilar

7

1 reference

18 December 2017

Joseph Kim

8

1 reference

18 December 2017

language of work or name

English

0 references

publication date

20 June 2011

1 reference

18 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

18 December 2017

volume

117

1 reference

18 December 2017

issue

24

1 reference

18 December 2017

page(s)

5493-5499

1 reference

18 December 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Adjuvant therapy for colon cancer: present and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

National Surgical Adjuvant Breast and Bowel Project trials in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Lymph node evaluation and survival after curative resection of colon cancer: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

Identification of patients with high-risk stage II colon cancer for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

NCCN Clinical Practice Guidelines in Oncology: colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26245

7 January 2021

Identifiers

DOI

10.1002/CNCR.26245

1 reference

18 December 2017

1 reference

18 December 2017